also found that CKS2 is significantly upregulated in breast cancer, and overexpression of CKS2 is associated with large tumor size, lack of progesterone receptor expression, poor tumor differentiation and reduced overall survival rate, and is an independent prognostic factor for breast cancer patients after radical resection (59). This evidence concerns the gene PGR and breast carcinoma.